Valley Forge, PA, United States of America

Philip E Sanderson

This inventor holds 27 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Msd K.k.. Active years: 1996-2014.

USPTO Granted Patents = 27 

% Patents Active = 81.5

 

 

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 182(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1996 - 2006)
  • Valley Forge, PA (US) (2008 - 2014)

Company Filing History:


Years Active: 1996-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Thrombin Inhibitors
AKT Activity Inhibitors
HIV Reverse Transcriptase
Naphthyridine Compounds
Pyrimidine Antagonists
Pyrazinone Compounds
Triazolo Compounds
Pyridinone Compounds
Piperidine Inhibitors
Hexahydropyridazine
Imidazopyridine
Pyrrolidine Inhibitors
27 patents (USPTO):Explore Patents

Title: The Inventor Philip E Sanderson: Pioneering Innovations in Valley Forge

Introduction: Philip E Sanderson is a distinguished inventor based in Valley Forge, Pennsylvania, known for his groundbreaking contributions to various fields.

Latest Patents: Philip E Sanderson holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Philip E Sanderson has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Philip E Sanderson has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Philip E Sanderson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…